Harte-Hanks, Inc. (HHS) News

Harte-Hanks, Inc. (HHS): $2.69

-0.06 (-2.18%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter HHS News Items

HHS News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Latest HHS News From Around the Web

Below are the latest news stories about Harte Hanks Inc that investors may wish to consider to help them evaluate HHS as an investment opportunity.

Harte Hanks to switch listing to OTCQX

Harte Hanks (HHS) to commence delisting procedure on NYSE in its failure to comply with the continued listing standardsThe company does not plan to appeal to NYSE for continue listing.The shares will begin trading on the OTCQX under the symbol HRTE. Source: Press Release...

Seeking Alpha | July 11, 2020

Harte Hanks, Inc. Announces Suspension Of Trading And Commencement Of NYSE Delisting Procedures; Common Stock Expected To Begin Trading On The OTCQX

Harte Hanks, Inc. (NYSE: HHS) (the "Company" or "Harte Hanks"), a leading data-driven multi-channel marketing solutions firm, today announced the Company was notified by the New York Stock Exchange ("NYSE") on July 9, 2020, that the NYSE had determined to commence proceedings to delist the Company's common stock (the "Common Stock") as a result of the Company's failure to comply with the continued listing standard set forth in Section 802.02B of the NYSE Listed Company Manual to maintain either (i) at least $50 million in stockholders' equity or (ii) at least $50 million in total market capitalization on a 30-trading day average basis. The NYSE will announce a suspension date at such time as (i) the Company does not request a review of...

Yahoo | July 10, 2020

All You Need to Know About Harte-Hanks (HHS) Rating Upgrade to Strong Buy

Harte-Hanks (HHS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 1 (Strong Buy).

Yahoo | June 5, 2020

Flagship Biosciences chooses Harte Hanks as marketing solutions partner.

Harte Hanks, Inc. (HHS), a leading behavioral marketing company, announced today that it has been selected by Flagship Biosciences to provide strategic marketing solutions in developing a new customer acquisition program. Flagship Biosciences is a leader in technology-driven tissue analysis, and provides expert tissue data insights to pharmaceutical, biotechnology and clinical diagnostic companies. Harte Hanks will be developing a targeted, multi-channel campaign including email, digital advertising and content creation to help Flagship Biosciences engage priority audiences, nurture leads and connect with potential clients.

Yahoo | June 3, 2020

Edited Transcript of HHS earnings conference call or presentation 12-Mar-20 8:30pm GMT

Q4 2019 Harte Hanks Inc Earnings Call

Yahoo | June 3, 2020

Edited Transcript of HHS earnings conference call or presentation 14-May-20 8:30pm GMT

Q1 2020 Harte Hanks Inc Earnings Call

Yahoo | May 26, 2020

Results: Harte Hanks, Inc. Confounded Analyst Expectations With A Surprise Profit

Harte Hanks, Inc. (NYSE:HHS) shareholders are probably feeling a little disappointed, since its shares fell 5.2% to...

Yahoo | May 17, 2020

Harte Hanks Reports First Quarter 2020 Financial Results

AUSTIN, Texas, May 14, 2020 -- Harte Hanks, Inc. (NYSE: HHS), an industry leader in data-driven, omnichannel marketing, and customer relationship solutions and logistics, today.

Yahoo | May 14, 2020

4 Advertising & Marketing Stocks to Gain Amid Coronavirus Scare

With strict lockdowns across the globe in the wake of coronavirus outbreak, people are spending more time indoor on various media platforms and streaming video services.

Yahoo | March 30, 2020

The CEO & Executive Chairman of Harte Hanks, Inc. (NYSE:HHS), Andrew Benett, Just Bought 13% More Shares

Even if it's not a huge purchase, we think it was good to see that Andrew Benett, the CEO & Executive Chairman of...

Yahoo | March 20, 2020


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 1.0013 seconds.